Immune Thrombocytopenic Purpura, Thyroid Disorders
Conditions
Brief summary
Prevalence of thyroid disorders in patients with immune thrombocytopenic purpura and its impact on treatment
Detailed description
We investigate patients with ITP for screening of thyroid disorders and how to deal with it and effect of this on the ttt
Interventions
DIAGNOSTIC_TESTSearch for thyroid disorders
TSH , FT3 , FT4
DIAGNOSTIC_TESTLaboratory test
Search for anti thyroid antibodies
DRUGSteroid and eltrombopage
See when we treat thyroid disorders, will patient respond to steroid or eltrombopage?
Sponsors
Assiut University
Study design
Observational model
OTHER
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* ITP patients will be classified as newly diagnosed, persistent and chronic based on duration less than 3 months, 3-12 months, and more than 12 months respectively. * refractory ITP patients.
Exclusion criteria
* patients with history of thyroidectomy * patients with history of drug induced ITP * patients with history of HCV, HBV and HIV infection. * Patients who refuse to contribute in this study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Assess the frequency of thyroid disorders in patients with IT | Assess the frequency of thyroid disorders in patients with IT | Screening of thyroid disorders in patients with ITP |
| Evaluate the treatment of thyroid disorders in improvement in platelets count. | Evaluate the treatment of thyroid disorders in improvement in platelets count. | Evaluate if patients have managed according to thyroid disorders, will this affect in their response to ITP management |
Outcome results
None listed